Hachim MY - Search Results

1

Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.

Hachim MY, Hachim IY, Dai M, Ali S, Lebrun JJ. Hachim MY, et al. Among authors: hachim iy. Tumour Biol. 2018 Jan;40(1):1010428317748254. doi: 10.1177/1010428317748254. Tumour Biol. 2018. PMID: 29320969 Free article.

2

Deciphering the Role of Insulin-Like Growth Factor 1 in Endometrial Cancer in Patients With Polycystic Ovary Syndrome: Protocol for a Methodological Approach Using Cell Culture Experiments.

Atiomo W, Alqutami F, Albasha S, Hachim M. Atiomo W, et al. JMIR Res Protoc. 2023 Nov 21;12:e48127. doi: 10.2196/48127. JMIR Res Protoc. 2023. PMID: 37988160 Free PMC article.

3

Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women.

Tabbal M, Hachim MY, Jan RK, Adrian TE. Tabbal M, et al. Among authors: hachim my. Front Genet. 2023 Jan 4;13:1039037. doi: 10.3389/fgene.2022.1039037. eCollection 2022. Front Genet. 2023. PMID: 36685821 Free PMC article.

4

Divulging a Pleiotropic Role of Succinate Receptor SUCNR1 in Renal Cell Carcinoma Microenvironment.

Najm R, Hachim MY, Kandasamy RK. Najm R, et al. Among authors: hachim my. Cancers (Basel). 2022 Dec 9;14(24):6064. doi: 10.3390/cancers14246064. Cancers (Basel). 2022. PMID: 36551549 Free PMC article.

5

In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers.

Kaddoura R, Alqutami F, Asbaita M, Hachim M. Kaddoura R, et al. Life (Basel). 2023 Feb 2;13(2):422. doi: 10.3390/life13020422. Life (Basel). 2023. PMID: 36836779 Free PMC article.

6

Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis.

Kaddoura R, Ghelani H, Alqutami F, Altaher H, Hachim M, Jan RK. Kaddoura R, et al. Life (Basel). 2023 Mar 2;13(3):680. doi: 10.3390/life13030680. Life (Basel). 2023. PMID: 36983834 Free PMC article.

7

Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.

Hachim IY, Hachim MY, Lopez VM, Lebrun JJ, Ali S. Hachim IY, et al. Among authors: hachim my. Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):238-45. doi: 10.1097/PAI.0000000000000178. Appl Immunohistochem Mol Morphol. 2016. PMID: 26317306

8

A dual prognostic role for the TGFβ receptors in human breast cancer.

Hachim IY, Hachim MY, López-Ozuna VM, Ali S, Lebrun JJ. Hachim IY, et al. Among authors: hachim my. Hum Pathol. 2016 Nov;57:140-151. doi: 10.1016/j.humpath.2016.07.002. Epub 2016 Jul 19. Hum Pathol. 2016. PMID: 27445263

9

Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.

López-Ozuna VM, Hachim IY, Hachim MY, Lebrun JJ, Ali S. López-Ozuna VM, et al. Among authors: hachim my, hachim iy. Sci Rep. 2016 Aug 2;6:30934. doi: 10.1038/srep30934. Sci Rep. 2016. PMID: 27480353 Free PMC article.

10

Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.

Tian J, Hachim MY, Hachim IY, Dai M, Lo C, Raffa FA, Ali S, Lebrun JJ. Tian J, et al. Among authors: hachim my, hachim iy. Sci Rep. 2017 Jan 5;7:40258. doi: 10.1038/srep40258. Sci Rep. 2017. PMID: 28054666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters